Taken together, our study lays important groundwork for the clinical translation of UTMC for targeted delivery of STAT3 decoy, and possibly other therapeutic oligonucleotides, for the treatment of HNSCC and other solid tumors. Here, STAT3 is linked to head and neck squamous cell carcinoma.